Pages that link to "Q24538818"

The following pages link to Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization (Q24538818):

Displaying 50 items.

• H5N1 viruses and vaccines (Q21131612) ‎ (← links)
• Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine (Q21134724) ‎ (← links)
• Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle (Q21562299) ‎ (← links)
• Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets (Q21563426) ‎ (← links)
• Confronting potential influenza A (H5N1) pandemic with better vaccines (Q24601560) ‎ (← links)
• H5N1 vaccines in humans (Q27000896) ‎ (← links)
• Advances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccines (Q27013568) ‎ (← links)
• Single-Dose Mucosal Immunization with a Candidate Universal Influenza Vaccine Provides Rapid Protection from Virulent H5N1, H3N2 and H1N1 Viruses (Q27318575) ‎ (← links)
• Pre-clinical evaluation of a replication-competent recombinant adenovirus serotype 4 vaccine expressing influenza H5 hemagglutinin (Q28731982) ‎ (← links)
• A single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1 (Q28752179) ‎ (← links)
• Emergence and pandemic potential of swine-origin H1N1 influenza virus (Q29619003) ‎ (← links)
• Production of adenovirus vectors and their use as a delivery system for influenza vaccines (Q30226988) ‎ (← links)
• Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target (Q30227194) ‎ (← links)
• A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses (Q30228657) ‎ (← links)
• Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of pre-existing immunity against human adenovirus (Q30229074) ‎ (← links)
• A subunit vaccine candidate derived from a classic H5N1 avian influenza virus in China protects fowls and BALB/c mice from lethal challenge. (Q30353796) ‎ (← links)
• A replicating modified vaccinia tiantan strain expressing an avian-derived influenza H5N1 hemagglutinin induce broadly neutralizing antibodies and cross-clade protective immunity in mice (Q30357094) ‎ (← links)
• Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. (Q30357521) ‎ (← links)
• Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. (Q30359842) ‎ (← links)
• Scientific barriers to developing vaccines against avian influenza viruses. (Q30360468) ‎ (← links)
• Protection of mice from H5N1 influenza challenge by prophylactic DNA vaccination using particle mediated epidermal delivery. (Q30362954) ‎ (← links)
• New pre-pandemic influenza vaccines: an egg- and adjuvant-independent human adenoviral vector strategy induces long-lasting protective immune responses in mice. (Q30365380) ‎ (← links)
• A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques. (Q30366868) ‎ (← links)
• The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus. (Q30367176) ‎ (← links)
• Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses. (Q30368699) ‎ (← links)
• Human infection with highly pathogenic H5N1 influenza virus. (Q30369081) ‎ (← links)
• A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses. (Q30369294) ‎ (← links)
• Protective immunity against influenza H5N1 virus challenge in chickens by oral administration of recombinant Lactococcus lactis expressing neuraminidase. (Q30373761) ‎ (← links)
• Development of a vaccine against pandemic influenza viruses: current status and perspectives. (Q30373784) ‎ (← links)
• Efficient strategy for constructing duck enteritis virus-based live attenuated vaccine against homologous and heterologous H5N1 avian influenza virus and duck enteritis virus infection. (Q30373912) ‎ (← links)
• Induction of long-term protective immune responses by influenza H5N1 virus-like particles. (Q30375255) ‎ (← links)
• Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines. (Q30375982) ‎ (← links)
• Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses. (Q30376925) ‎ (← links)
• Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin (Q30380290) ‎ (← links)
• Recombinant vectors as influenza vaccines. (Q30380898) ‎ (← links)
• Pandemic influenza vaccines. (Q30380902) ‎ (← links)
• Mucosal immunity induced by adenovirus-based H5N1 HPAI vaccine confers protection against a lethal H5N2 avian influenza virus challenge. (Q30381722) ‎ (← links)
• Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses. (Q30382097) ‎ (← links)
• MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization. (Q30382567) ‎ (← links)
• Animal models for the preclinical evaluation of candidate influenza vaccines. (Q30383623) ‎ (← links)
• Several hemagglutinins of same serotype for induction of broad immunity against influenza A virus antigenic drift variants: WO2008048984. (Q30385956) ‎ (← links)
• A candidate H1N1 pandemic influenza vaccine elicits protective immunity in mice (Q30389068) ‎ (← links)
• Update on antivirals and vaccines for seasonal and potential pandemic use. (Q30389265) ‎ (← links)
• Viral vector-based influenza vaccines (Q30390938) ‎ (← links)
• Chimpanzee adenovirus vector-based avian influenza vaccine completely protects mice against lethal challenge of H5N1. (Q30392386) ‎ (← links)
• Construction of a recombinant duck enteritis virus vaccine expressing hemagglutinin of H9N2 avian influenza virus and evaluation of its efficacy in ducks (Q30393796) ‎ (← links)
• Immunoprotection against influenza H5N1 virus by oral administration of enteric-coated recombinant Lactococcus lactis mini-capsules (Q30393856) ‎ (← links)
• Comparative immunogenicity of recombinant adenovirus-vectored vaccines expressing different forms of hemagglutinin (HA) proteins from the H5 serotype of influenza A viruses in mice (Q30394323) ‎ (← links)
• Yeast Surface-Displayed H5N1 Avian Influenza Vaccines (Q30397351) ‎ (← links)
• Single dose of oil-adjuvanted inactivated vaccine protects chickens from lethal infections of highly pathogenic H5N1 influenza virus (Q30397710) ‎ (← links)